IBDEI03R ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1049,0)
 ;;=K82.9^^12^125^2
 ;;^UTILITY(U,$J,358.3,1049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1049,1,3,0)
 ;;=3^Gallbladder Disease,Unspec
 ;;^UTILITY(U,$J,358.3,1049,1,4,0)
 ;;=4^K82.9
 ;;^UTILITY(U,$J,358.3,1049,2)
 ;;=^5008875
 ;;^UTILITY(U,$J,358.3,1050,0)
 ;;=K92.2^^12^125^6
 ;;^UTILITY(U,$J,358.3,1050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1050,1,3,0)
 ;;=3^Gastrointestinal Hemorrhage,Unspec
 ;;^UTILITY(U,$J,358.3,1050,1,4,0)
 ;;=4^K92.2
 ;;^UTILITY(U,$J,358.3,1050,2)
 ;;=^5008915
 ;;^UTILITY(U,$J,358.3,1051,0)
 ;;=K25.9^^12^125^3
 ;;^UTILITY(U,$J,358.3,1051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1051,1,3,0)
 ;;=3^Gastric Ulcer w/o Hemorrhage/Perforation
 ;;^UTILITY(U,$J,358.3,1051,1,4,0)
 ;;=4^K25.9
 ;;^UTILITY(U,$J,358.3,1051,2)
 ;;=^5008522
 ;;^UTILITY(U,$J,358.3,1052,0)
 ;;=I69.959^^12^126^11
 ;;^UTILITY(U,$J,358.3,1052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1052,1,3,0)
 ;;=3^Hemiplegia/Hemiparesis Following Unspec Cerebrovascular Disease
 ;;^UTILITY(U,$J,358.3,1052,1,4,0)
 ;;=4^I69.959
 ;;^UTILITY(U,$J,358.3,1052,2)
 ;;=^5007563
 ;;^UTILITY(U,$J,358.3,1053,0)
 ;;=D89.2^^12^126^22
 ;;^UTILITY(U,$J,358.3,1053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1053,1,3,0)
 ;;=3^Hypergammaglobulinemia,Unspec
 ;;^UTILITY(U,$J,358.3,1053,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,1053,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,1054,0)
 ;;=B19.10^^12^126^15
 ;;^UTILITY(U,$J,358.3,1054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1054,1,3,0)
 ;;=3^Hepatitis B w/o Hepatic Coma
 ;;^UTILITY(U,$J,358.3,1054,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,1054,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,1055,0)
 ;;=B17.10^^12^126^17
 ;;^UTILITY(U,$J,358.3,1055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1055,1,3,0)
 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
 ;;^UTILITY(U,$J,358.3,1055,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,1055,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,1056,0)
 ;;=B18.2^^12^126^18
 ;;^UTILITY(U,$J,358.3,1056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1056,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,1056,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,1056,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,1057,0)
 ;;=E03.9^^12^126^31
 ;;^UTILITY(U,$J,358.3,1057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1057,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,1057,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,1057,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,1058,0)
 ;;=E16.2^^12^126^28
 ;;^UTILITY(U,$J,358.3,1058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1058,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,1058,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,1058,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,1059,0)
 ;;=E78.0^^12^126^21
 ;;^UTILITY(U,$J,358.3,1059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1059,1,3,0)
 ;;=3^Hypercholesterolemia,Pure
 ;;^UTILITY(U,$J,358.3,1059,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,1059,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,1060,0)
 ;;=E78.1^^12^126^23
 ;;^UTILITY(U,$J,358.3,1060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1060,1,3,0)
 ;;=3^Hyperglyceridemia,Pure
 ;;^UTILITY(U,$J,358.3,1060,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,1060,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,1061,0)
 ;;=E78.5^^12^126^26
 ;;^UTILITY(U,$J,358.3,1061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1061,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,1061,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,1061,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,1062,0)
 ;;=E78.4^^12^126^25
 ;;^UTILITY(U,$J,358.3,1062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1062,1,3,0)
 ;;=3^Hyperlipidemia,Other
